Efficacy of tigecycline on serum procalcitonin and its efficacy in elderly COPD and nosocomial infection
10.3969/j.issn.1005-1678.2017.01.061
- VernacularTitle:替加环素对老年COPD并院内感染患者血清降钙素原的影响及临床疗效
- Author:
Weibiao WANG
;
Dai LI
;
Hong TENG
;
Youfa ZHENG
- Keywords:
tigecycline;
COPD;
elderly;
nosocomial infection;
procalcitonin
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(1):207-209,213
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of tigecycline on serum procalcitonin and its efficacy in the treatment of elderly chronic obstructive pulmonary disease (COPD) and nosocomial infection. Methods 82 elderly patients with COPD with nosocomial infection were selected and randomly divided into two groups with 41 cases of each group, the control group received routine treatment combined with cefoperazone and sulbactam, and the experimental group received routine treatment combined with tigecycline, 2 weeks for a course of treatment. The serum inflammatory factors and laboratory related indexes, clinical efficacy and bacterial clearance were compared after the treatment. Results Compared with control group, the levels of serum high-sensitivity C-reactive protein (hs-CRP), interluekin 6(IL-6) and tumor necrosis factorα(TNF-α) were significantly lower, and the serum levels of PCT and NO were lower(P < 0.05). The total efficacy of experimental group was 90.24%, which was higher than 70.73% in control group (P<0.05). The bacterial clearance rate in the control group was 63.42%, which was lower than the experimental group of 87.80% (P < 0.05). Conclusion Tigecycline in the treatment of COPD and nosocomial infection in elderly patients is curative effective and it can reduce the serum levels of PCT, NO and inflammatory factors with high safety.
